During the Neogene period, humanity’s primate ancestors held a genomic advantage for combating gout. A new study found that the gene effectively lowered levels of uric acid and prevented ...

AstraZeneca has dropped the lead candidate from its $200 million buyout of Neogene Therapeutics as part of a wider cell therapy clearout. When AstraZeneca scooped up the company back in 2022, ...